Stock data
Cabaletta Bio, Inc. (CABA)
Cabaletta Bio, Inc. (CABA) reported net income of -US$167.86M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$172.24M | -US$167.86M | — |
| 2024 | — | — | -US$125.14M | -US$115.86M | — |
| 2023 | — | — | -US$74.66M | -US$67.67M | — |
| 2022 | — | — | -US$54.14M | -US$52.98M | — |
| 2021 | — | — | -US$46.31M | -US$46.29M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$51.02M | — |
| 2026-03-31 | — | -US$43.52M | — |
| 2025-12-31 | — | -US$41.92M | — |
| 2025-09-30 | — | -US$44.87M | — |
| 2025-06-30 | — | -US$45.13M | — |
| 2025-03-31 | — | -US$35.94M | — |
| 2024-12-31 | — | -US$32.59M | — |
| 2024-09-30 | — | -US$30.63M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.